{ "items": [ "\n\n
\n \n 23 November 2022\n \n
\n\n \n \n \n\n \n \n \nData showing 7.7 million deaths from 33 bacterial infections can guide measures to strengthen health systems, particularly in low-income settings
\n \n\n\n \n 22 November 2022\n \n
\n\n \n \n \n\n \n \n \nA new Oxford University study released during World Antimicrobial Awareness Week has significant findings on how antimicrobial resistance (AMR) arises and persists. The results, published today in Nature Communications, provide the first direct evidence of AMR bacteria migrating from a patient\u2019s gut microbiome to the lungs, increasing the risk of deadly infections.
\n \n\n\n \n 7 November 2022\n \n
\n\n \n \n \n\n \n \n \nResearchers from the University of Oxford have today reported findings from a study that investigated whether previously identified correlates of protection associated with risk of full-blown tuberculosis (TB) disease could also be associated with risk of infection from the bacteria that causes TB - highlighting certain correlates in the process.
\n \n\n\n \n 4 November 2022\n \n
\n\n \n\n \n\n \n \n \n \n Jenner\n \n \n\n \n\n\n
\n \n\n \n \n \nA phase I/IIa clinical trial that the University of Oxford collaborated on has demonstrated that a T-cell therapeutic HIV vaccine was associated with better control of the virus rebound when antiretroviral therapy (ART) was temporarily withdrawn.
\n \n\n\n \n 31 October 2022\n \n
\n\n \n \n \n\n \n \n \nDr Anna Furmanski has recently been appointed as Course Director for the MSc in Integrated Immunology programme ahead of Professor Jon Austyn\u2019s retirement after 19 years in the role. Dr Furmanski is an experienced educator, course leader, academic supervisor, and research immunologist.
\n \n\n\n \n 27 October 2022\n \n
\n\n \n \n \n\n \n \n \nOxford University has been ranked as the world's best institution for clinical and health teaching and research for the twelfth consecutive year in the latest Times Higher Education World University Rankings.
\n \n\n\n \n 11 October 2022\n \n
\n\n \n\n \n\n \n \n \n \n Kennedy\n \n \n\n \n\n\n
\n \n\n \n \n \nThe Leducq Foundation has awarded $7.5 million to researchers at the University of Oxford and their collaborators to advance immunotherapy as a treatment for cardiovascular disease, the leading cause of death in the UK.
\n \n\n\n \n 23 September 2022\n \n
\n\n \n \n \n\n \n \n \nAround 15% of people aged 40-75 may have a form of undiagnosed high blood pressure (hypertension) that occurs only at night-time. Because they do not know about this, and therefore are not being treated for it, they are at a higher risk of cardiovascular disease such as stroke, heart failure, and even death, suggests new research from the University of Oxford published in the British Journal of General Practice.
\n \n\n\n \n 16 September 2022\n \n
\n\n \n\n \n\n \n \n \n \n DPAG\n \n \n\n \n\n\n
\n \n\n \n \n \nResearchers in Department of Physiology, Anatomy and Genetics have identified a rescue mechanism that allows cancers to overcome the consequences of inactivating mutations in critically important genes.
\n \n\n\n \n 9 September 2022\n \n
\n\n \n \n \n\n \n \n \nWe join with so many others across the country, and the world, in sadness at the passing of Her Majesty Queen. Elizabeth II. The University enjoyed a close relationship with The Queen throughout her reign and gives thanks for her 70 years of service to the nation.
\n \n\n\n \n 8 September 2022\n \n
\n\n \n \n \n\n \n \n \nResearchers from the University of Oxford and their partners have today reported new findings from their Phase 2b trial following the administration of a booster dose of the candidate malaria vaccine, R21/Matrix-M\u2122 \u2013 which previously demonstrated high-level efficacy of 77% over the following 12 months in young west African children in 2021.
\n \n\n\n \n 6 September 2022\n \n
\n\n \n\n \n\n \n \n \n \n Paediatrics\n \n \n\n \n\n\n
\n \n\n \n \n \nResearchers in Oxford have launched the first UK study in the general population to test for early markers of type 1 diabetes before children develop symptoms or need insulin.
\n \n\n\n \n 5 September 2022\n \n
\n\n \n \n \n\n \n \n \n \n \n\n\n \n 11 August 2022\n \n
\n\n \n \n \n\n \n \n \nResearchers from the University of Oxford, KTH Royal Institute of Technology, Science for Life Laboratory, and the Karolinska Institutet, Solna, Sweden, have found that individual prostate tumours contain a previously unknown range of genetic variation.
\n \n\n\n \n 2 August 2022\n \n
\n\n \n \n \n\n \n \n \nResearchers from Oxford\u2019s Institute of Population Ageing, Tufts University and the University of Manchester have discovered that common viruses appear to play a role in some cases of Alzheimer\u2019s disease (AD).
\n \n\n\n \n 1 August 2022\n \n
\n\n \n\n \n\n \n \n \n \n Paediatrics\n \n \n\n \n\n\n
\n \n\n \n \n \nOxford University\u2019s Professor Teresa Lambe, the designer of the vaccine, fears Marburg disease is \u2018now being seen in places where it\u2019s never been seen before\u2019
\n \n\n\n \n 28 July 2022\n \n
\n\n \n \n \n\n \n \n \nResearchers from the University of Oxford have today reported new findings from a Phase 1 clinical trial studying the immune response and safety of their newly-developed single shot rabies vaccine, ChAdOx2 RabG - with promising results identified.
\n \n\n\n \n 15 July 2022\n \n
\n\n \n\n \n\n \n \n \n \n Jenner\n \n \n\n \n\n\n
\n \n\n \n \n \nWhen the University of Oxford developed a vaccine that was effective against COVID-19, ensuring that it could be rolled out globally and in perpetuity for low- and middle-income countries was of paramount importance.
\n \n\n\n \n 14 July 2022\n \n
\n\n \n\n \n\n \n \n \n \n Paediatrics\n \n \n\n \n\n\n
\n \n\n \n \n \nResearchers from Oxford\u2019s Department of Paediatrics have discovered that infection can increase a baby\u2019s sensitivity to pain, which may last longer than the infection.
\n \n\n\n \n 13 July 2022\n \n
\n\n \n \n \n\n \n \n \nThe University of Oxford's newest research institute, the Institute of Developmental & Regenerative Medicine (IDRM), has been officially opened, launching the first institute of its kind in the world to physically merge developmental biology and regenerative medicine to treat some of the world's most prolific diseases.
\n \n\n